⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7209291 | 1.00 | — | — | |
| SCHEMBL10041943 | 1.00 | — | — | |
| SCHEMBL12810045 | 1.00 | — | — | |
| SCHEMBL10013538 | 1.00 | — | — | |
| SCHEMBL332747 | 1.00 | — | — | |
| SCHEMBL10231804 | 1.00 | — | — | |
| SCHEMBL7214312 | 1.00 | — | — | |
| SCHEMBL10013536 | 1.00 | — | — | |
| SCHEMBL26823589 | 0.88 | LMNA (0.31) | — | |
| SCHEMBL13800901 | 0.86 | CA2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | claimed |
| US-10428104-B2 | Substituted nucleoside derivatives useful as anticancer agents | PFIZER INC. (US) | 2019-10-01 | — | — | US | disclosed |
| US-9580455-B2 | Process for the recovery of beta acetylfuranoside | HOFFMANN-LA ROCHE INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-9580455-B2 | Process for the recovery of beta acetylfuranoside | HOFFMANN-LA ROCHE INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-20160333040-A9 | Novel Process for the Recovery of Beta Acetylfuranoside | HOFFMANN-LA ROCHE INC. (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160333040-A9 | Novel Process for the Recovery of Beta Acetylfuranoside | HOFFMANN-LA ROCHE INC. (US) | 2016-11-17 | — | — | US | disclosed |
| US-20130072674-A1 | Novel Process for the Recovery of Beta Acetylfuranoside | HOFFMANN-LA ROCHE INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-20130072674-A1 | Novel Process for the Recovery of Beta Acetylfuranoside | HOFFMANN-LA ROCHE INC. (US) | 2013-03-21 | — | — | US | disclosed |
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | disclosed |
| US-20100190976-A1 | NOVEL PROCESS FOR THE RECOVERY OF BETA ACETYLFURANOSIDE | F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) | 2010-07-29 | — | — | US | disclosed |
| US-20100190976-A1 | NOVEL PROCESS FOR THE RECOVERY OF BETA ACETYLFURANOSIDE | F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) | 2010-07-29 | — | — | US | disclosed |
| WO-2008105593-A1 | METHOD FOR STEREOSELECTIVE PREPARATION AND SEPARATION OF TRI-O-ACETYL-5-DEOXY-ß-D-RIBOFURANOSE | HANMI PHARM. CO., LTD. (KR) | 2008-09-04 | — | — | WO | disclosed |
| US-7081449-B2 | Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides | VALEANT RESEARCH & DEVELOPMENT (US) | 2006-07-25 | — | — | US | disclosed |
| US-6831069-B2 | Having substituents at the C4' and C5' positions of the ribofuranose moiety; anticancer and immunomodulating effects at reduced cytotoxicity; treating autoimmune diseases, cancer, dermatitis | RIBAPHARM INC. | 2004-12-14 | — | — | US | disclosed |
| US-20030144502-A1 | Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides | MDRNA RESEARCH, INC. | 2003-07-31 | — | — | US | disclosed |
| US-20020035077-A1 | Pyrrolo[2,3-d]pyrimidine nucleoside analogs | CEQUENT PHARMACEUTICALS, INC. | 2002-03-21 | — | — | US | disclosed |
| US-5360795-A | Treating cytomegalo virus and herpes simplex viruses | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1994-11-01 | — | — | US | disclosed |